PRELUDE?
Faced with a past with little progress, great challenges are foreseen in
the future, since dissatisfaction around unmet needs is added to the
issue of sexual orientation, identity and gender, reinforcing the
notability of the exclusion of this portion of citizens, who have left
out of clinical research and the development of specific
policies11. In addition, the significant impacts of
the COVID-19 pandemic are also beginning to be perceived in
contraception and PRp, with a 9.1% drop in the number of women using
contraception12,13.
Achieve progress in order to meet the reproductive intentions of women
will only occur when investments in health are guided by the quality
procedures and largely attend the population, covering age groups,
social levels and varied profiles14. Given the
challenges presented and aiming to minimize the financial impacts, the
damming of demand experienced should be absorbed by the health system in
the coming years, the IMP-ETN can be considered a contraceptive option
of clinical and socioeconomic interest to public and private sector of
health.
World Health Organization lists limited access to good quality services
and choice of method; experience, or fear, of side effects; cultural or
religious opposition, user and provider bias, and gender-based barriers
as potential reasons for women not using available contraceptive
methods. Changes in infrastructure and better training of providers to
educate, especially about the predilection for LARCs, would be good
initiatives to achieve lower rates of unplanned pregnancies and
abortions.